LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q4 EPS of $0.01, $0.01 better than the analyst estimate of $0.00. Revenue for the quarter came in at $382.2 million versus the consensus estimate of $378.45 million.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.